E Fund CSI Innovative Drugs ETF (516080.SH) Stock Community - Hot Topic Discussions - Longbridge

For Institutions
- Corporate Services
- Developers
Download
Help
About

Markets

Information

Affiliate Program

Promotions

EN

English

简体中文

繁體中文

繁體中文（廣東話）Posts & comments will be shown in Cantonese

Search...

Quote List Quote List

© 2025 Longbridge｜Disclaimer

Event Tracking

Dec19

Hengrui Pharmaceutical's Subsidiary Obtains Clinical Trial Approval for Leuprorelin Acetate Microspheres Injection

12:01

Hengrui Medicine Subsidiary Receives Clinical Trial Approval Notice for SHR-2906 Injection

08:57

Fosun Pharma Aims to Acquire Green Valley for Continued Clinical Trials of 'Nine-Seven-One'

00:18

Dec18

Fosun Pharmaceutical Industry Co., Ltd. signs Cooperation and Option Agreement with ClavisBio

10:22

WuXi Biologics Shareholders Reduce Holdings, Stake Drops to 16.97%

09:47

WuXi Lux Holding Subsidiary Acquires Fund Investment and Transfers Shares

09:23